Enara Bio
Jonathan Porter is an accomplished professional in the field of intellectual property, currently serving as Head of Intellectual Property and Senior Director at Enara Bio since January 2021. Prior to this role, Jonathan held the position of Director of Intellectual Property and European Patent Attorney at Adaptimmune from September 2019 to January 2021, and served as Senior Patent Attorney at Pfizer from December 2001 to September 2019. Jonathan's educational background includes a BSc in Biology from the University of Birmingham, a PhD in Biochemistry, Biophysics, and Molecular Biology from the University of Bristol, and an LLB (Hons) from The Open University.
This person is not in any offices
Enara Bio
Enara Bio’s mission is to shine a light on unconventional targets and develop the next generation of cancer immunotherapies designed to treat a broad patient population. Enara Bio is exploring the hidden depths of cancer and T-cell biology to discover and characterize novel immunotherapy targets, such as MR1-presented ligands and Dark Antigens™, which arise from altered cellular processes in cancer cells.